Distribution of COVID Test Kits without FDA Approval, Clearance or Authorization.
Source facts
Action
On 08/08/2022, GS Biomark emailed customer to notify them that their COVID test kits - CoViPoint COVID test kit (MultiPLEX/Direct) have expired and to destroy unused material
that they still have on-hand.
Customer were not informed that the affected products did not have Emergency Use Authorization to distributed the product within the U.S.
Initiated
2022-08-08
Root cause
No Marketing Application
Distribution
U.S.: TX, NY, GA, IN, MD, CA, PA, MD, DC, NJ, OR, WA
O.U.S.: None
Recall number
Z-0324-2023
Recall status
Open, Classified
CDRH record ID
196556
FDA classified
2022-11-29
Recall event number
91032
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.